Skip to main content

Oncology Startups

Updated July 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 295 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
295
Total Funding
$728.1M
Avg Funding
$29.1M
Global Reach
7
countries

Top Cities for Oncology

Yongsan
Wilmington
Medford
Philadelphia
Plymouth Meeting
Watertown

Recently Funded Companies

Export
Yongsan, South Korea

Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.

$17.8M raised
Dec 2023

Founder Contacts

30,000+ verified contacts

Wilmington, United States

Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.

$102.0M raised
Dec 2023

Founder Contacts

30,000+ verified contacts

Medford, United States

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

$10.0M raised
Oct 2023

Founder Contacts

30,000+ verified contacts

Philadelphia, United States

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

$5.0M raised
Oct 2023

Founder Contacts

30,000+ verified contacts

Plymouth Meeting, United States

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

$5.0M raised
Sep 2023

Founder Contacts

30,000+ verified contacts

Watertown, United States

Mariana Oncology is a biotechnology research industry.

$175.0M raised
Sep 2023

Founder Contacts

30,000+ verified contacts

California City, United States

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

$52.5M raised
Aug 2023

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

$20.0M raised
Aug 2023

Founder Contacts

30,000+ verified contacts

Seattle, United States

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

$14.0M raised
May 2023

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

$8.0M raised
May 2023

Founder Contacts

30,000+ verified contacts

Boston, United States

Xsphera Biosciences is a biotechnology startup that focuses on delivering functional, precision immuno-oncology solutions.

$12.6M raised
May 2023

Founder Contacts

30,000+ verified contacts

Greensboro, United States

Fuse Oncology provides business and clinical intelligence solution for radiation oncology.

$8.9M raised
Apr 2023

Founder Contacts

30,000+ verified contacts

Vancouver, Canada

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

$142.0M raised
Apr 2023

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Droplet Biosciences can offer earlier and more accurate cancer diagnosis by using lymphatic fluid.

$8.0M raised
Mar 2023

Founder Contacts

30,000+ verified contacts

Pittsburgh, United States

Duo Oncology develops a new nanoparticle technology specially tailored to penetrate established tumors.

$3.0M raised
Feb 2023

Founder Contacts

30,000+ verified contacts

Fukuoka, Japan

Beads is a hospice housing organisation that provides hospice housing and independent living facility.

$6.3M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Parsippany, United States

Onkos Surgical is a surgical oncology company that develops implants and instruments for musculoskeletal tumor patients.

$30.0M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Utrecht, The Netherlands

Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses.

$3.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

New Haven, United States

AtlasXomics is a biotechnology company accelerating spatial multi-omics for application in oncology, neurology, and aging.

$3.9M raised
Jan 2022

Founder Contacts

30,000+ verified contacts

Palo Alto, United States

Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.

$25.0M raised
Jan 2023

Founder Contacts

30,000+ verified contacts

Phoenix, United States

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

$60.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Edinburgh, United Kingdom

Carcinotech is a MedTech company with expertise in manufacturing 3D printed living tumours for cancer research

$5.3M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Minnesota City, United States

Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.

$9.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

São Paulo, Brazil

Comsentimento enriches and connects data to improve care and accelerate cancer research.

$286K raised
Dec 2022

Founder Contacts

30,000+ verified contacts

Vancouver, Canada

Publicly traded (RKV.V) company focused on the development of new cancer treatments based on novel DNA-damage response technologies.

$1.5M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Showing 201 to 225 of 295 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 295 oncology companies tracked in the VCBacked database.

Average Funding
$29.1M
Total Funding Tracked
$728.1M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.Cambridge
3 companies$36.0M
2.Vancouver
2 companies$143.5M
3.Yongsan
1 companies$17.8M
4.Wilmington
1 companies$102.0M
5.Medford
1 companies$10.0M

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked